This award, the only one in France dedicated to non-animal research and supported by Fondation Descroix-Vernier and Comité Scientifique Pro Anima recognizes innovative, rigorous research projects conducted without animal experimentation. It aims to encourage promising research and teams based on the exceptional quality of their work.
The award ceremony took place on March 28, 2025, at the French Senate, Palais du Luxembourg, Paris, when we have received a trophy and funding to continue our research.
The project « ObFAT-3D: 3D ex vivo human tissues to mimic obese adipose tissue » is based on our ExAdEx patented technology that closely reproduces the physiopathological responses of human adipose tissue. By combining transcriptomic and functional analyses, we aim to:
« This award is a significant recognition of the scientific and medical potential of our work. It strengthens our commitment to more ethical research and accelerates our mission: to provide researchers and industry with revolutionary tools, directly usable in the laboratory and easily manipulable, to develop more effective and patient-adapted therapies more quickly« , says Vincent Dani.
ObFAT-3D project is co-funded by ExAdEx-Innov in collaboration with Institute of Molecular and Cellular Pharmacology (IPMC) team directed by Dr Bernard Mari and Dr Georges Vassaux, IdEx Innovation Program France 2030 of Université Côte d’Azur and the Association Nationale de la Recherche et de la Technologie (ANRT) funding of a CIFRE PhD program.
To read the program description: ObFAT-3D
ExAdEx-Innov contributes to Landmark Review on Nanofat in Regenerative Medicine We are delighted to announce the publication of our latest collaborative research with our partners
ExAdEx-Innov is set to showcase its most recent dermo-cosmetic research on its proprietary 3D vascularized adult tissue models at COMET Congress 2025 The COMET Congress,
ExAdEx-Innov Drives Innovation in Cosmetic Industry: Contributing to the Development of VividEye™ from Mibelle Biochemistry We are thrilled to announce ExAdEx-Innov’s contribution to the research
Copyright © 2022 ExAdEx-Innov All rights reserved
KOL on adipose tissue biology.
Research Director (DR1 INSERM).
Team Leader of « Stem Cells and Differentiation » Lab at Institut de Biologie Valrose (Nice).
Label of Laboratoire d’Excellence by the French National Research Agency (Investissements pour le Futur, Labex Signalife program).
Co-inventor of 5 patents
Expert in clinical applications of adipose tissue.
Plastic Reconstructive and Aesthetic Surgeon in Nice.
Member of the Medical Council of Alpes Maritimes region.
Expert for the French National Regulatory Agency ANSM for medical devices.
Certified by French Health Autority HAS (2020-2024).
PhD thesis (2018) on fat tissue and adipose tissue stem cells grafting.
Expert in cell therapy and immunology.
Senior Lecturer (Maitre de conférences).
Responsible of the Cell and Gene Therapy Unity of Nice University Hospital (CHU de Nice).
Director of « Micoralis » research team at Université Côte d’Azur (Nice).
Founder and CEO of the biotech company Biointerférence (2003-2006).
Co-inventor of 5 patents.
Vincent is responsible of company strategy and technological innovation, thanks to his double skill set in science and deeptech startup development.
With a deep knowledge and vision about ExAdEx technology, Vincent has actively worked as a deeptech entrepreneur to push further the development of breakthrough innovative products around human adipose tissue, which lead him to create ExAdEx-Inov.
In addition to his entrepreneurial skills, Vincent has a strong background in biology (PhD in Cellular and Molecular Biology from Université Côte d’Azur) and training in clinical research management (CRA training at the Faculty of Medicine of La Timone, Marseille).
He is co-inventor of the 2 company’s patent families.
Main areas of expertise: DeepTech entrepreneur; Bioengineering of human adipose tissue.
Luigi is responsible of the management of company operations and business development strategy, thanks to his expertise in biotech startup development.
With a double competence and training in business and science (including an MBA from IAE Paris Sorbonne Business School and a PhD in Cytological Sciences from Rome University La Sapienza), Luigi has been managing business development and R&D projects in a preclinical CRO and a biotech startup company in previous years.
He has been supporting ExAdEx-Innov project and business development since his position as an Entrepreneur in Residence for CNRS Innovation Tech Transfer Office in 2021.
Main areas of expertise: Biotech Startup Business Development; Project management
